RCM
MRNA icon

Raleigh Capital Management’s Moderna MRNA Stock Holding History

Raleigh Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-85
Closed -$3.53K – 854
2024
Q4 		$3.53K Buy
85
+20
+31% +$956 ﹤0.01% 757
2024
Q3 		$4.34K Sell
65
-91
-58% -$8.36K ﹤0.01% 715
2024
Q2 		$18.5K Buy
156
+40
+34% +$5.06K 0.01% 441
2024
Q1 		$12.4K Buy
116
+81
+231% +$8.16K 0.01% 521
2023
Q4 		$3.48K Buy
+35
New +$2.94K ﹤0.01% 802
2022
Q1 		– Sell
-2
Closed -$1K – 650
2021
Q4 		$1K Buy
+2
New +$585 ﹤0.01% 292

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raleigh Capital Management's MRNA Position: Q1 2025 in Review

Raleigh Capital Management sold out of Moderna (MRNA) in Q1 2025, closing a stake of 85 shares — an estimated $3.53K sold.

Raleigh Capital Management first reported a position in MRNA in Q4 2021 and held it in 6 quarters. The position peaked at $18.5K in Q2 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Raleigh Capital Management reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 85 Moderna shares in Q1 2025, an estimated $3.53K.
  • Raleigh Capital Management first reported a position in Moderna in Q4 2021 and held it in 6 quarters.
  • Raleigh Capital Management's Moderna position peaked at $18.5K in Q2 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Raleigh Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.